Board/Management Information • Mar 13, 2017
Board/Management Information
Open in ViewerOpens in native device viewer
Lyon (France), March 13th, 2017 - AMOEBA (FR0011051598 - AMEBA), manufacturer of a biological biocide capable of eliminating bacterial risk in water, announced today the appointment of Arnaud MERIENNE as General Manager of the company, effective from March 13th , 2017.
The main goals of Arnaud MERIENNE are to strengthen the structure of the company in order to sustain growth and to deploy the production units on the European, American and Asian continents. This development will be carried out in accordance with the values of the company laid down by its founder President, Fabrice PLASSON.
Arnaud MERIENNE has 25 years' experience in the process industry, in particular in the cement industry within the Lafarge group. During his career, he held various operational responsibilities as well as key functional roles at international level, specifically on the management of industrial performance, internal audit and human resources. He successfully led many change projects to gain operational excellence and industrial competitivity.
His 15 years' experience spent in different countries including Canada, Austria, Italy and Greece have given him a strong capacity to manage change in an environment in constant evolution. Arnaud MERIENNE is 51 years' old and graduated from French Ecole Polytechnique, and Ecoles Ponts et chaussées in Paris and Madrid.
« AMOEBA is an innovative company with a disruptive technology holding a promising future. It meets the main environmental issues in water treatment and enables its customers to greatly improve their competitivity. I am very pleased to join the team at AMOEBA to make my contribution to the development of the company. » stated Arnaud MERIENNE, General Manager of AMOEBA.
« The experience of Arnaud MERIENNE gained at the highest level in a large industrial group is a major asset to accelerate the next steps of structuration and industrialization of our company. Besides managing Arnaud and the group finances, I will keep the development of the company in the long term through the definition of the strategy, investors' relations and lobbying activities. I am convinced that Arnaud will be able to develop his solid industry expertise to achieve AMOEBA's ambitions beyond our expectations. » stated Fabrice PLASSON, President of AMOEBA's Board of Directors.
AMOEBA develops a biological biocide capable of eliminating waterborne bacterial risk (legionella, pseudomonas, listeria, etc.). This entirely natural solution is presented as an alternative to the chemical treatments traditionally used in the industrial sector and complies with the new regulations in terms of chemical emissions into the environment. In a worldwide market for chemical biocides estimated to be worth EUR 21 bn(1), AMOEBA is today concentrating on the segment of industrial air-cooled towers (ACT), estimated to be worth EUR 1.7 bn(2). AMOEBA is continuing with the regulatory procedures necessary to obtain provisional MA for all European countries for the "Air Cooled Towers" application. Based in Lyon-Chassieu (France), AMOEBA is quoted on compartment C of the Euronext Paris stock exchange and joined the CAC® Small index on 21st September 2015. For more information: www.amoeba-biocide.com.
(1): Sources combined by Amoeba from water treatment agencies, Freedonia, Eurostat and MarketsandMarkets (2): Amoeba data combined from the following sources: DRIRE 2013, Eurostat, ARHIA 2013
Amoéba Nathalie COMBROUSSE Marketing Communication Manager Tel. : +33 (0)4 81 09 18 15 [email protected]
Actifin Ghislaine GASPARETTO Financial Communication Tel. : +33 (0)1 56 88 11 11 [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.